In3 is recruiting

Marie Skłodowska-Curie Action

The in3 project is funded by the EU's Marie Skłodowska-Curie Action - Innovative Training Network. It aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial (NM) safety assessment. Overall, 15 PhD students carry out these activities in a coordinated and highly collaborative fashion and one of these will be located at DC working on Data management and Bioinformatics.

During her/his fellowship, the student will have the chance to work closely with the group of Marcel Leist at the University of Konstanz and another academic partner in the network, take scientific and soft-skills training and to work on her/his thesis leading to a PhD degree awarded by the University of Konstanz.

Recruitment is open now and will remain open until all positions are filled. (Please check the requirements for applications including existing master degree in an area relevant to the project, being in the first 4 years of their research career and living outside of Switzerland for at least 3 years before the appointment).

 

Dr Thomas Exner is a Chief Scientific Officer (CSO) at Douglas Connect

 

Add new comment

About Douglas Connect

Douglas Connect manages collaborative projects to achieve goals in scientific research, infrastructure development or service provision. Effective collaboration requires many elements including coordination, culture, communications, common understanding, decision-making and interoperability.

Tags

Latest Tweets

Douglas Connect (2 weeks ago)
https://t.co/BYmTVjxqvr
Douglas Connect (2 weeks ago)
https://t.co/TfiARTZk2m
Douglas Connect (3 weeks ago)
Join us at OpenTox USA 2018, July 11-12, in Raleigh-Durham. Our theme for this year will be: Maximizing the benefit… https://t.co/1pyQhx88Kx
Douglas Connect (4 weeks ago)
This is the first announcement for an additional eChemInfo Training and Innovation Course in Drug Design 3-7 Septe… https://t.co/36eMROXQ6Q
Douglas Connect (4 weeks ago)
Evidence-based medicine has proven its worth. So, how do we now apply it to toxicology? Learn more:… https://t.co/XzRni13iRf

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com